Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Castagna

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|February 23, 2018
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Blood Advances|January 15, 2020
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphomaArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Haematologica|July 25, 2015
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patientsRoberto Crocchiolo, Luca Castagna, Sylvain Garciaz, et al.
Bone Marrow Transplantation|October 10, 2022
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working partyNicole Santoro, Jarl E Mooyaart, Raynier Devillier, et al.
Bone Marrow Transplantation|December 30, 2022
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignanciesRémy Duléry, Claire Goudet, Daniele Mannina, et al.
Blood|March 7, 2015
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantationAlessandra Roberto, Luca Castagna, Veronica Zanon, et al.
Haematologica|October 31, 2024
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant-eligible newly diagnosed multiple myeloma: a multicenter real-world experienceMarika Porrazzo, Tiziana Moscato, Giuseppe Sapienza, et al.
Haematologica|November 27, 2014
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trialDidier Blaise, Raynier Devillier, Anne-Gaëlle Lecoroller-Sorriano, et al.
Bone Marrow Transplantation|December 14, 2022
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working partyNicole Santoro, Jarl E Mooyaart, Raynier Devillier, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|February 23, 2018
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Blood Advances|January 15, 2020
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphomaArmando Santoro, Rita Mazza, Alessandro Pulsoni, et al.
Haematologica|July 25, 2015
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patientsRoberto Crocchiolo, Luca Castagna, Sylvain Garciaz, et al.
Bone Marrow Transplantation|October 10, 2022
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working partyNicole Santoro, Jarl E Mooyaart, Raynier Devillier, et al.
Bone Marrow Transplantation|December 30, 2022
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignanciesRémy Duléry, Claire Goudet, Daniele Mannina, et al.
Blood|March 7, 2015
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantationAlessandra Roberto, Luca Castagna, Veronica Zanon, et al.
Haematologica|October 31, 2024
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant-eligible newly diagnosed multiple myeloma: a multicenter real-world experienceMarika Porrazzo, Tiziana Moscato, Giuseppe Sapienza, et al.
Haematologica|November 27, 2014
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trialDidier Blaise, Raynier Devillier, Anne-Gaëlle Lecoroller-Sorriano, et al.
Bone Marrow Transplantation|December 14, 2022
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working partyNicole Santoro, Jarl E Mooyaart, Raynier Devillier, et al.
Pageof 21